Physician

Devon L Evans, MD

According to 2025 Medicare claims, Devon Evans, MD (NPI: 1518183532) practices hematology/oncology in the Portland-South Portland, ME market, with the plurality of this provider's patient population coming from Cumberland, ME. This provider's primary affiliated billing organization is MAINE CENTER FOR CANCER MEDICINE & BLOOD DISORDERS, P.A. (NPI: 1205896107; TIN: 010357684) and primary practice location at 04092-4877. Evans is affiliated with the MaineHealth Accountable Care Organization (ACO ID: A1290), Aledade 205 New England MSSP Enhanced (ACO ID: A5370), and Beacon Rural Health, LLC (ACO ID: A5614), participating under the MSSP model.

Evans' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 645 traditional Medicare patients, billed 210,396 HCPCS/CPT codes, and received $4,180,869 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,460 prescription claims across 246 beneficiaries totaling $7,200,753 in drug costs, led by Revlimid (Lenalidomide). DME data shows 51 claims. Open Payments data shows 9 records totaling $388. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,950,155 to $4,180,869. Similarly, Part D prescription costs have risen steadily, from $896,869 to $7,200,753. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $8,392 to $407.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.3M$4.7M2015 Medicare payment: $1,950,155 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,198,146 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,784,708 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,637,523 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,659,338 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $4,415,484 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,321,421 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,042,500 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,765,582 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,180,869 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015520138,452$1,950,155
2016550142,711$2,198,146
2017509143,784$2,784,708
2018609186,502$3,637,523
2019574211,490$4,659,338
2020584203,763$4,415,484
2021699204,638$4,321,421
2022744211,603$4,042,500
2023654209,207$3,765,582
2024645210,396$4,180,869

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.6M$7.2M2015 Drug cost: $896,869 (USD; Tot_Drug_Cst)2016 Drug cost: $1,320,420 (USD; Tot_Drug_Cst)2017 Drug cost: $1,030,151 (USD; Tot_Drug_Cst)2018 Drug cost: $1,256,208 (USD; Tot_Drug_Cst)2019 Drug cost: $978,874 (USD; Tot_Drug_Cst)2020 Drug cost: $1,058,616 (USD; Tot_Drug_Cst)2021 Drug cost: $1,770,008 (USD; Tot_Drug_Cst)2022 Drug cost: $3,532,323 (USD; Tot_Drug_Cst)2023 Drug cost: $4,384,066 (USD; Tot_Drug_Cst)2024 Drug cost: $7,200,753 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015172941$896,869
20161751,037$1,320,420
2017166952$1,030,151
2018162907$1,256,208
2019141703$978,874
2020158613$1,058,616
2021167847$1,770,008
20222021,111$3,532,323
20232091,190$4,384,066
20242461,460$7,200,753

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$18K$37K2015 Medicare payment: $9,886 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $36,674 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $18,222 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $3,276 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $3,680 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $4,181 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,604 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $2,999 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,221 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R132$9,886
2016N/R99$36,674
2017N/R84$18,222
2018N/R24$3,276
2019N/RN/RN/R
2020N/R51$3,680
2021N/R72$4,181
2022N/R27$1,604
2023N/R34$2,999
2024N/R51$1,221

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more289957$95
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less126297$48
80053Blood test, comprehensive group of blood chemicals254857$10
36415Insertion of needle into vein for collection of blood sample242735$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count273968$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide511,428$807,635
ErleadaApalutamide421,260$623,329
PomalystPomalidomide29678$518,898
VerzenioAbemaciclib31868$496,830
TepmetkoTepotinib Hcl18540$442,787

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8521Capecitabine, oral, 500 mgNN/R20$637
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R31$583

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.9$388AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Devon L. Evans, MD?

Tedicare shows public-source Medicare data for Devon L. Evans, MD (NPI 1518183532), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Devon L. Evans, MD have ACO affiliation data?

Devon L. Evans, MD is shown with ACO affiliation data for MaineHealth Accountable Care Organization (MSSP, ACO ID A1290), Aledade 205 New England MSSP Enhanced (MSSP, ACO ID A5370), and Beacon Rural Health, LLC (MSSP, ACO ID A5614).

What billing organization is linked to Devon L. Evans, MD?

Devon L. Evans, MD is linked to MAINE CENTER FOR CANCER MEDICINE & BLOOD DISORDERS, P.A. (billing NPI 1205896107) in the available physician profile data.

Does Devon L. Evans, MD have Open Payments data?

Devon L. Evans, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.